Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

End in sight for GHTF; new regulators-only forum on horizon

This article was originally published in Clinica

Executive Summary

The founding members of the Global Harmonization Task Force have agreed to terminate the body and are proposing to replace it with a regulators-only forum in the future. The GHTF for the past 18 years or so has been working towards developing a regulatory model and supporting documents to underpin globally harmonised regulation of medical devices.

You may also be interested in...



EU Clinical Trial Portal Requires Rethink On Balancing Business Interests & Transparency

In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.

Launch Of EU Clinical Trial Portal Moves A Step Closer

An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.

EU Mandates Monthly Safety Summaries For Approved COVID-19 Vaccines

EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.

Topics

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel